GC
Garde Capital Portfolio holdings
AUM
$1.87B
1-Year Return
14.67%
This Quarter Return
-1.71%
1 Year Return
+14.67%
3 Year Return
+58.47%
5 Year Return
+86.48%
10 Year Return
+153.43%
AUM
$1.75B
AUM Growth
+$230M
(+15%)
Cap. Flow
+$279M
Cap. Flow
% of AUM
15.95%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
856
New
577
Increased
54
Reduced
93
Closed
52
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
+$115M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$50.1M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$47.2M |
| 4 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$31.7M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$29.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$4.16M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$3.37M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.89M |
| 4 |
Vanguard FTSE Pacific ETF
VPL
|
+$1.5M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.47M |
Sector Composition
| 1 | Technology | 5.32% |
| 2 | Communication Services | 3.13% |
| 3 | Consumer Discretionary | 2.02% |
| 4 | Financials | 0.82% |
| 5 | Consumer Staples | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Verisk Analytics
VRSK
$37.5B
| $1.49K | ﹤0.01% |
+5
| New | +$1.49K |
|
602
Organon & Co
OGN
$2.7B
| $1.43K | ﹤0.01% |
+96
| New | +$1.43K |
|
603
Dynatrace
DT
$15.3B
| $1.42K | ﹤0.01% |
+30
| New | +$1.42K |
|
604
TE Connectivity
TEL
$61.7B
| $1.41K | ﹤0.01% |
+10
| New | +$1.41K |
|
605
ProShares UltraPro S&P 500
UPRO
$4.58B
| $1.41K | ﹤0.01% |
+19
| New | +$1.41K |
|
606
Southern Copper
SCCO
$81.1B
| $1.4K | ﹤0.01% |
+15
| New | +$1.4K |
|
607
Nokia
NOK
$24.7B
| $1.4K | ﹤0.01% |
+265
| New | +$1.4K |
|
608
Halliburton
HAL
$18.5B
| $1.4K | ﹤0.01% |
+55
| New | +$1.4K |
|
609
TransDigm Group
TDG
$73.9B
| $1.38K | ﹤0.01% |
+1
| New | +$1.38K |
|
610
Solid Power
SLDP
$685M
| $1.38K | ﹤0.01% |
+1,316
| New | +$1.38K |
|
611
Tractor Supply
TSCO
$31.3B
| $1.38K | ﹤0.01% |
+25
| New | +$1.38K |
|
612
Builders FirstSource
BLDR
$15.5B
| $1.38K | ﹤0.01% |
+11
| New | +$1.38K |
|
613
DexCom
DXCM
$30.7B
| $1.37K | ﹤0.01% |
+20
| New | +$1.37K |
|
614
Eaton
ETN
$136B
| $1.36K | ﹤0.01% |
+5
| New | +$1.36K |
|
615
Alnylam Pharmaceuticals
ALNY
$63.2B
| $1.35K | ﹤0.01% |
+5
| New | +$1.35K |
|
616
HEICO
HEI
$44B
| $1.34K | ﹤0.01% |
+5
| New | +$1.34K |
|
617
Amphenol
APH
$143B
| $1.31K | ﹤0.01% |
+20
| New | +$1.31K |
|
618
EOG Resources
EOG
$64.1B
| $1.28K | ﹤0.01% |
+10
| New | +$1.28K |
|
619
Ally Financial
ALLY
$12.7B
| $1.28K | ﹤0.01% |
+35
| New | +$1.28K |
|
|
HQL
620
abrdn Life Sciences Investors
HQL
$411M
| $1.27K | ﹤0.01% |
+100
| New | +$1.27K |
|
621
Unum
UNM
$12.5B
| $1.22K | ﹤0.01% |
+15
| New | +$1.22K |
|
622
Molson Coors Class B
TAP
$9.78B
| $1.22K | ﹤0.01% |
+20
| New | +$1.22K |
|
623
SPDR S&P Biotech ETF
XBI
$5.48B
| $1.22K | ﹤0.01% |
+15
| New | +$1.22K |
|
624
Genuine Parts
GPC
$19.3B
| $1.19K | ﹤0.01% |
+10
| New | +$1.19K |
|
625
ARK Fintech Innovation ETF
ARKF
$1.36B
| $1.17K | ﹤0.01% |
+35
| New | +$1.17K |
|